Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neural networks to identify multiple sclerosis with optical coherence tomography.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
[Update of the treatment of multiple sclerosis].
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Primary Sjögren's syndrome related optic neuritis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
MS nurses join project to prove the value of specialist role.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
Epstein-Barr virus in multiple sclerosis.
The fumaric acid ester BG-12: a new option in MS therapy.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »